Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
Open Access
- 15 July 2021
- journal article
- letter
- Published by Elsevier BV in The Lancet Microbe
- Vol. 2 (9), e423-E423
- https://doi.org/10.1016/s2666-5247(21)00177-4
Abstract
No abstract availableKeywords
Funding Information
- Health and Medical Research Fund
This publication has 5 references indexed in Scilit:
- Evidence for antibody as a protective correlate for COVID-19 vaccinesVaccine, 2021
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Correlates of Vaccine-Induced Protection against SARS-CoV-2Vaccines, 2021
- Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster SeraJournal of Clinical Microbiology, 2021
- Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020Eurosurveillance, 2020